NCT04487080

AUG 20, 2026 · PHASE 3 TRIAL

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 RCT registry record with no posted results; the study is active but not recruiting, and outcomes remain unreported in this source.